Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review

Tahlita C.M. Zuiverloon(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Hedvig Vékony(Erasmus University Rotterdam), Annemieke J.M. Nieuweboer(Erasmus University Rotterdam), Chris H. Bangma(Erasmus University Rotterdam), Wim J. Kirkels(Erasmus MC)

European Urology

October 13, 2011

10.1016/j.eururo.2011.09.026

Cited by 175

Related Papers

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

|European Urology|2017|793

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

|Cancer Cell|2016|654

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

|European Urology|2015|639

Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.

|Proceedings of the National Academy of Sciences|1989|493

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

|Nature Communications|2021|381